News
BioNTech präsentiert auf der ASCO-Jahrestagung 2025 Fortschritte aus der diversifizierten Onkologie-Pipeline
MAINZ, Deutschland, 27. Mai 2025 -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der Jahrestagung der American Society of Clinical Oncology („ASCO“), die vom 30. Mai bis 3
Pfizer's 7.5% Dividend: Income Haven or House of Cards?
A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income-seeking
3 Trades Members of Congress Are Making Right Now
Whether or not members of Congress should be allowed to buy or sell stocks is another topic. Retail investors should keep their eyes on the ball. That means, if investors can’t beat them, they may
Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?
When investors choose to risk their capital in an individual company, they must be aware that the stock market isn’t the one-sided machine it used to be a few decades ago. Thanks to the flow of
Sanofi Stock: $600M Alzheimer Drug Acquisition Bet
Sanofi has made a strategic move to strengthen its neurology portfolio by acquiring Vigil Neuroscience for up to $600 million. The French pharmaceutical giant will pay $470 million ($8 per share)
Pfizer Stock: Billion-Dollar Chinese Cancer Drug Deal
Pharmaceutical giant Pfizer is making significant strategic moves in oncology, investing up to $6 billion in a licensing deal with Chinese biotech firm 3SBio. The agreement centers on SSGJ-707, a
How Does D-Wave Stack Up Against Quantum Competitors?
D-Wave Quantum Inc. (NYSE: QBTS) has emerged as one of the most talked-about stocks in the quantum computing industry, a space investors are watching
Regeneron Stock: Pharma Giant Bets on Genetic Data
Regeneron Pharmaceuticals is set to acquire the bankrupt genetic testing company 23andMe for $256 million, gaining access to a massive database of 15 million DNA profiles. The bold move, announced
UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
Despite the healthcare sector's reputation for stability, UnitedHealth Group (NYSE: UNH) has recently faced significant market turbulence.
By mid-May
UnitedHealth Stock: Justice Department Probe Triggers Freefall
UnitedHealth Group finds itself in severe turmoil as shares plummeted nearly 11% to $245.90 following news of a U.S. Justice Department criminal investigation into potential Medicare fraud. The
Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025
As of mid-May 2025, the S&P 500 has turned positive year-to-date (YTD) for the first time in many weeks. Stocks across multiple sectors have broadly recovered from the jolt of tariff news and
Merck Stock: Solid Q1 Overshadowed by Lowered Outlook
Merck KGaA delivered impressive first-quarter results for 2025, with net profit climbing 5.5% to €738 million and earnings per share reaching €1.69, representing a 5.6% increase compared to the same
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this
iTeos verkündet Topline-Zwischenergebnisse der GALAXIES Lung-201-Studie für die First-Line-Behandlung mit Belrestotug und Dostarlimab von Krebspatienten, die von einem nicht-kleinzelligen Lungenkarzinom mit hoher PD-L1-Expression betroffen sind
– GALAXIES Lung-201 erfüllte nicht die festgelegten Kriterien für klinisch bedeutsame Verbesserungen beim progressionsfreien Überleben
– Ausgehend von der Gesamtheit der Daten haben sich iTeos und
Best Biotech Stocks to Buy in 2025
The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector.
Biotech stocks lagged the broader market
EQS-News: Carl Zeiss Meditec erzielt Umsatzwachstum und stabilen operativen Gewinn im ersten Halbjahr 2024/25
Top Analyst-Rated Healthcare Stocks to Watch Now
It has been a turbulent start to the year for the healthcare industry, as concerns about major cuts to Medicare and Medicaid coincide with the impact of tariffs on supplies and many other
Lonza gibt Ergebnisse der Generalversammlung 2025 bekannt – Alle Anträge des Verwaltungsrates wurden genehmigt
Tempus AI Stock: Time to Double Down or Cut and Run?
Tempus AI (NASDAQ: TEM) is an interesting AI story that operates a platform and library for diagnosis and drug discovery. The platform aids physicians
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) market, delivering outstanding first-quarter 2025 financial results that
Vertex-Studie: Führende Unternehmen im globalen Steuer- und Finanzwesen setzen zunehmend auf e-Invoicing
Die Studie von Vertex zeigt eine starke Unterstützung für E-Invoicing-Mandate unter globalen Steuer- und Finanzverantwortlichen.
KING OF PRUSSIA, Penn., May 07, 2025 (GLOBE NEWSWIRE) -- Vertex
EQS-News: Wechsel an Vorstandsspitze der Carl Zeiss Meditec AG
EQS-Adhoc: Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG
BioNTech veröffentlicht Ergebnisse für das erste Quartal 2025 sowie Informationen zur Geschäftsentwicklung
- Weiterentwicklung der Onkologie-Pipeline vorangetrieben mit strategischem Fokus auf zwei tumorübergreifende (Pan-Tumor-)Programme: Immunmodulator-Kandidat BNT327, ein gegen PD-L1 und VEGF-A1
BioNTech ernennt Ramón Zapata zum neuen Finanzvorstand
Mainz, Deutschland, 5. Mai 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) gab heute bekannt, dass der Aufsichtsrat Ramón Zapata-Gomez mit Wirkung zum 1. Juli